Literature DB >> 17322345

Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis.

E Burum-Auensen1, P M Deangelis, A R Schjølberg, Jo Røislien, S N Andersen, O P F Clausen.   

Abstract

BACKGROUND: Long term ulcerative colitis (UC) increases the risk of colorectal cancer (CRC). DNA aneuploidy is a common feature of both dysplastic and non-dysplastic colonic epithelia from patients with longstanding UC, and is regarded as an early sign of possible malignant transformation. The spindle proteins Aurora A, BUB1B and Mad2 have been implicated as contributors to aneuploidy and carcinogenesis. AIMS: To investigate the role of these spindle proteins in relation to DNA aneuploidy and during the progressive morphological changes in ulcerative colitis associated colorectal cancer (UCCRC).
METHODS: Tissue microarrays were made from 31 colectomy specimens from patients with longstanding UC. Expression of Aurora A, BUB1B and Mad2 was investigated by immunohistochemistry and their relation to ploidy status, mucosal morphology and Ki67 levels was explored.
RESULTS: Expression of Aurora A and BUB1B was significantly associated with the progressive morphological changes of UCCRC. In the progression from non-dysplastic to dysplastic mucosa, Aurora A expression decreased while BUB1B expression increased. There was an increasing incidence of aneuploidy with progression towards cancer; expression of all spindle proteins was associated with the level of Ki67 but not with aneuploidy.
CONCLUSION: Due to the significant differences in Aurora A and BUB1B expression in dysplastic compared non-dysplastic mucosa, these proteins may serve as putative biological markers for the progressive morphological changes in UC associated carcinogenesis. The close relationship to Ki67 levels reflect that spindle proteins are expressed in tissues with a high proliferative rate; a role for these proteins in the development of aneuploidy was not found.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322345      PMCID: PMC2095563          DOI: 10.1136/jcp.2006.044305

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  45 in total

1.  THE CANCER RISK IN ULCERATIVE COLITIS.

Authors:  I P MACDOUGALL
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia.

Authors:  R F Willenbucher; D E Aust; C G Chang; S J Zelman; L D Ferrell; D H Moore; F M Waldman
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis.

Authors:  J O Lindberg; R B Stenling; J N Rutegård
Journal:  Br J Surg       Date:  1999-07       Impact factor: 6.939

Review 4.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.

Authors:  Steven H Itzkowitz; Xianyang Yio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07       Impact factor: 4.052

5.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

6.  Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.

Authors:  Shareen H Doak; Gareth J S Jenkins; Elizabeth M Parry; A Paul Griffiths; John N Baxter; James M Parry
Journal:  Mutat Res       Date:  2004-03-22       Impact factor: 2.433

7.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.

Authors:  L L Vindeløv; I J Christensen; N I Nissen
Journal:  Cytometry       Date:  1983-03

8.  Mortality in ulcerative colitis.

Authors:  S Gyde; P Prior; M J Dew; V Saunders; J A Waterhouse; R N Allan
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

9.  Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.

Authors:  Geert J P L Kops; Daniel R Foltz; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

10.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.

Authors:  H Zhou; J Kuang; L Zhong; W L Kuo; J W Gray; A Sahin; B R Brinkley; S Sen
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

View more
  22 in total

1.  A new role for Drosophila Aurora-A in maintaining chromosome integrity.

Authors:  Chiara Merigliano; Elisa Mascolo; Anthony Cesta; Isabella Saggio; Fiammetta Vernì
Journal:  Chromosoma       Date:  2019-01-05       Impact factor: 4.316

2.  Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysis.

Authors:  Rüdiger Meyer; Sandra Freitag-Wolf; Silke Blindow; Jürgen Büning; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2016-10-20       Impact factor: 2.571

3.  BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis.

Authors:  Ye Yang; Chunyan Gu; Chen Luo; Fei Li; Min Wang
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

4.  Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.

Authors:  J Bargiela-Iparraguirre; L Prado-Marchal; N Pajuelo-Lozano; B Jiménez; R Perona; I Sánchez-Pérez
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors.

Authors:  Espen Burum-Auensen; Rolf I Skotheim; Aasa R Schjølberg; Jo Røislien; Ragnhild A Lothe; Ole Petter F Clausen
Journal:  J Carcinog       Date:  2010-03-04

6.  Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.

Authors:  E Burum-Auensen; P M DeAngelis; A R Schjølberg; J Røislien; O Mjåland; O P F Clausen
Journal:  Cell Prolif       Date:  2008-08       Impact factor: 6.831

7.  Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands.

Authors:  Avijeet S Chopra; Anton Kuratnik; Eric W Scocchera; Dennis L Wright; Charles Giardina
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

8.  BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.

Authors:  Kiyoshi Takagi; Yasuhiro Miki; Yukiko Shibahara; Yasuhiro Nakamura; Akiko Ebata; Mika Watanabe; Takanori Ishida; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2013-01-04       Impact factor: 3.869

9.  miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation.

Authors:  Gaia Buoli Comani; Roberto Panceri; Marco Dinelli; Andrea Biondi; Clara Mancuso; Raffaella Meneveri; Donatella Barisani
Journal:  Genes Nutr       Date:  2015-08-02       Impact factor: 5.523

10.  BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.

Authors:  Y-K Lee; E Choi; M A Kim; P-G Park; N-H Park; H Lee
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.